A citation-based method for searching scientific literature

Debyani Chakravarty, Elmer Santos, Mabel Ryder, Jeffrey A Knauf, Xiao-Hui Liao, Brian L West, Gideon Bollag, Richard Kolesnick, Tin Htwe Thin, Neal Rosen, Pat Zanzonico, Steven M Larson, Samuel Refetoff, Ronald Ghossein, James A Fagin. J Clin Invest 2011
Times Cited: 240



Laurie L Carr, David A Mankoff, Bernardo H Goulart, Keith D Eaton, Peter T Capell, Elizabeth M Kell, Julie E Bauman, Renato G Martins. Clin Cancer Res 2010
Times Cited: 288




List of shared articles



Times cited

Emerging drugs for the treatment of radioactive iodine refractory papillary thyroid cancer.
Sophie Leboulleux, Livia Lamartina, Julien Hadoux, Eric Baudin, Martin Schlumberger. Expert Opin Investig Drugs 2022
0

Multikinase inhibitors in thyroid cancer: timing of targeted therapy.
Matti L Gild, Venessa H M Tsang, Roderick J Clifton-Bligh, Bruce G Robinson. Nat Rev Endocrinol 2021
18

Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm.
Vincenzo Marotta, Maria Grazia Chiofalo, Francesca Di Gennaro, Antonio Daponte, Fabio Sandomenico, Paolo Vallone, Luciana Costigliola, Gerardo Botti, Franco Ionna, Luciano Pezzullo. Crit Rev Oncol Hematol 2021
4

Early Predictive Response to Multi-Tyrosine Kinase Inhibitors in Advanced Refractory Radioactive-Iodine Differentiated Thyroid Cancer: A New Challenge for [18F]FDG PET/CT.
Cristina Ferrari, Giulia Santo, Rossella Ruta, Valentina Lavelli, Dino Rubini, Paolo Mammucci, Angela Sardaro, Giuseppe Rubini. Diagnostics (Basel) 2021
1

Mouse models of thyroid cancer: Bridging pathogenesis and novel therapeutics.
Yuchen Jin, Min Liu, Ri Sa, Hao Fu, Lin Cheng, Libo Chen. Cancer Lett 2020
9

Kinase Inhibitors in the Treatment of Thyroid Cancer: Institutional Experience.
Matea Pešorda, Sanja Kusačić Kuna, Dražen Huić, Davorin Herceg, Marija Despot, Tatjana Samardžić, Milena Gnjidić, Borislav Belev. Acta Clin Croat 2020
2

Novel Drug Treatments of Progressive Radioiodine-Refractory Differentiated Thyroid Cancer.
Steven P Weitzman, Steven I Sherman. Endocrinol Metab Clin North Am 2019
12

Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond.
Maria E Cabanillas, Mabel Ryder, Camilo Jimenez. Endocr Rev 2019
113

Clinical guidance for radioiodine refractory differentiated thyroid cancer.
Matti L Gild, Duncan J Topliss, Diana Learoyd, Francis Parnis, Jeanne Tie, Brett Hughes, John P Walsh, Donald S A McLeod, Roderick J Clifton-Bligh, Bruce G Robinson. Clin Endocrinol (Oxf) 2018
14